Lenvatinib and Lyme disease vaccine (recombinant ospa) Intramuscular
Determining the interaction of Lenvatinib and Lyme disease vaccine (recombinant ospa) Intramuscular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: n.a.
Generic Name: lyme disease vaccine
Brand name:
Synonyms: Lyme disease vaccine (recombinant ospa)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib-Lymepak
- Lenvatinib-Lymphocyte immune globulin, anti-thymocyte equine
- Lenvatinib-Lymphoseek
- Lenvatinib-Lynparza
- Lenvatinib-Lynparza (Olaparib Capsules)
- Lenvatinib-Lynparza (Olaparib Tablets)
- Lyme disease vaccine (recombinant ospa) Intramuscular-Lenvatinib Mesylate
- Lyme disease vaccine (recombinant ospa) Intramuscular-Lenvima
- Lyme disease vaccine (recombinant ospa) Intramuscular-Lenvima (14 MG Daily Dose)
- Lyme disease vaccine (recombinant ospa) Intramuscular-Lenvima (18 MG Daily Dose)
- Lyme disease vaccine (recombinant ospa) Intramuscular-Lenvima (20 MG Daily Dose)
- Lyme disease vaccine (recombinant ospa) Intramuscular-Lenvima (24 MG Daily Dose)